Cargando…

Risk factors for forced expiratory volume in 1 s decline in European patients with cystic fibrosis: data from the European Cystic Fibrosis Society Patient Registry

AIM: To examine the trajectory of forced expiratory volume in 1 s (FEV(1)) using data from the European Cystic Fibrosis Society patient registry (ECFPR) collected from 2008 to 2016, i.e. the era before highly effective modulator therapy (HEMT). We evaluated risk factors for FEV(1) decline. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hatziagorou, Elpis, Fieuws, Steffen, Orenti, Annalisa, Naehrlich, Lutz, Krivec, Uros, Mei-Zahav, Meir, Jung, Andreas, De Boeck, Kris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2023
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359040/ https://www.ncbi.nlm.nih.gov/pubmed/37483280 http://dx.doi.org/10.1183/23120541.00449-2022

Ejemplares similares

Predictors of Reduced Survival for Adult-diagnosed Cystic Fibrosis: Older Age at Diagnosis, a Substitute for Older Age?
por: Fieuws, Steffen, et al.
Publicado: (2019)

Association of Oxygen Therapy with the Natural Disease Progression of Cystic Fibrosis: A Multi-State Model of the European Cystic Fibrosis Society Patient Registry
por: Gambazza, Simone, et al.
Publicado: (2023)

Reference percentiles for FEV(1) and BMI in European children and adults with cystic fibrosis
por: Boëlle, Pierre-Yves, et al.
Publicado: (2012)

Editorial: Cystic Fibrosis in Children
por: Karadag, Bülent Taner, et al.
Publicado: (2022)

Pancreatic Cystosis in Two Adolescents with Cystic Fibrosis
por: Hatziagorou, Elpis, et al.
Publicado: (2016)

Cystic Fibrosis Mortality in Childhood. Data from European Cystic Fibrosis Society Patient Registry
por: Zolin, Anna, et al.
Publicado: (2018)

The Changing Face of Cystic Fibrosis and Its Implications for Screening
por: Naehrlich, Lutz
Publicado: (2020)

Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe
por: Jung, Andreas, et al.
Publicado: (2021)

European Cystic Fibrosis Society Standards of Care: Framework for the Cystic Fibrosis Centre
por: Conway, Steven, et al.
Publicado: (2014)

Physical Activity and Quality of Life among Patients with Cystic Fibrosis
por: Giannakoulakos, Stavros, et al.
Publicado: (2022)

International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety
por: Quittner, Alexandra L, et al.
Publicado: (2016)

The Fitter the Better? Cardiopulmonary Exercise Testing Can Predict Pulmonary Exacerbations in Cystic Fibrosis
por: Kampouras, Asterios, et al.
Publicado: (2021)

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
por: Floto, R Andres, et al.
Publicado: (2016)

Impact of COVID-19 on people with cystic fibrosis
por: Colombo, Carla, et al.
Publicado: (2020)

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary
por: Floto, R Andres, et al.
Publicado: (2016)

Cystic Fibrosis Screen Positive, Inconclusive Diagnosis Genotypes in the Cystic Fibrosis Registry
por: Thompson, Cassandra, et al.
Publicado: (2023)

The European Cystic Fibrosis Society Patient Registry: valuable lessons learned on how to sustain a disease registry
por: Viviani, Laura, et al.
Publicado: (2014)

Disease-specific clinical trials networks: the example of cystic fibrosis
por: De Boeck, Kris, et al.
Publicado: (2016)

Effects of a Long-Term Wearable Activity Tracker-Based Exercise Intervention on Cardiac Morphology and Function of Patients with Cystic Fibrosis
por: Anifanti, Maria, et al.
Publicado: (2022)

Toward the Establishment of New Clinical Endpoints for Cystic Fibrosis: The Role of Lung Clearance Index and Cardiopulmonary Exercise Testing
por: Hatziagorou, Elpis, et al.
Publicado: (2021)

Assessment of serology and spirometry and the combination of both to complement microbiological isolation for earlier detection of Pseudomonas aeruginosa infection in children with cystic fibrosis
por: Kotnik Pirš, Ana, et al.
Publicado: (2016)

Risk factors for respiratory Aspergillus fumigatus in German Cystic Fibrosis patients and impact on lung function
por: Düesberg, Uta, et al.
Publicado: (2020)

Dynamic Hyperinflation While Exercising—A Potential Predictor of Pulmonary Deterioration in Cystic Fibrosis
por: Shmueli, Einat, et al.
Publicado: (2023)

Modified forced expiration technique using expiratory resistance in adults with cystic fibrosis
por: Watson, Kathryn, et al.
Publicado: (2023)

Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis
por: Ashkenazi, Moshe, et al.
Publicado: (2018)

Epidemiology of Nontuberculous Mycobacteria Infection in Children and Young People With Cystic Fibrosis: Analysis of UK Cystic Fibrosis Registry
por: Gardner, Aaron I, et al.
Publicado: (2019)

Diabetes in Cystic Fibrosis: Multicenter Screening Results Based on Current Guidelines
por: Scheuing, Nicole, et al.
Publicado: (2013)

The Diagnosis of Cystic Fibrosis in Adult Age. Data from the Italian Registry
por: Padoan, Rita, et al.
Publicado: (2021)

Incidence of SARS-CoV-2 in people with cystic fibrosis in Europe between February and June 2020
por: Naehrlich, Lutz, et al.
Publicado: (2021)

The clinical yield of bronchoscopy in the management of cystic fibrosis: A retrospective multicenter study
por: Gileles‐Hillel, Alex, et al.
Publicado: (2022)

Serum Proteome Profiling Identifies Novel and Powerful Markers of Cystic Fibrosis Liver Disease
por: Rath, Timo, et al.
Publicado: (2013)

Cystic Fibrosis
por: Gibson, Lewis E.
Publicado: (1969)

Cystic Fibrosis
por: Dodge, J A
Publicado: (1997)

Intestinal current measurement versus nasal potential difference measurements for diagnosis of cystic fibrosis: a case–control study
por: Bagheri-Hanson, Azadeh, et al.
Publicado: (2014)

Data Resource Profile: The UK Cystic Fibrosis Registry
por: Taylor-Robinson, David, et al.
Publicado: (2018)

Erratum to: Epidemiology of Nontuberculous Mycobacteria Infection in Children and Young People With Cystic Fibrosis: Analysis of UK Cystic Fibrosis Registry
Publicado: (2021)

Mediation of the total effect of cystic fibrosis‐related diabetes on mortality: A UK Cystic Fibrosis Registry cohort study
por: Tanner, Kamaryn T., et al.
Publicado: (2022)

Comparative demographics of the European Cystic Fibrosis population: does EU membership confer an advantage?
por: Mehta, Anil, et al.
Publicado: (2010)

A Comparative Analysis of Pricing and Reimbursement of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Europe
por: Abdallah, Khadidja, et al.
Publicado: (2021)

Personalized medicine with drugs targeting the underlying protein defect in cystic fibrosis: is monitoring of treatment response necessary?
por: Niedermayr, Katharina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bbpus9pgdchapigj0lkqqn8rdf